Corporate Presentation

RNS Number : 8949E
Alkemy Capital Investments PLC
16 March 2022
 

 

16 March 2022

 

Alkemy Capital Investments Plc

 

Corporate Presentation  

 

Alkemy Capital Investments plc ("Alkemy" or the "Company") is pleased to announce that its wholly-owned subsidiary Tees Valley Lithium Limited ("TVL") has posted a corporate presentation on its website www.teesvalleylithium.co.uk

 

About Tees Valley Lithium

TVL has been established to finance and construct a lithium hydroxide processing facility in Teesside, UK. TVL is aiming to supply 15% of Europe's demand by 2030.

 

Further information

For further information, please visit the Company's website: www.alkemycapital.co.uk or www.teesvalleylithium.co.uk

-Ends-

 

Sam Quinn  
Director - Alkemy Capital Investments Plc
Telephone: 0207 317 0636

Email: info@alkemycapital.co.uk  

 

 

Forward Looking Statements

This news release contains forward‐looking information. The statements are based on reasonable assumptions and expectations of management and Alkemy provides no assurance that actual events will meet management's expectations. In certain cases, forward‐looking information may be identified by such terms as "anticipates", "believes", "could", "estimates", "expects", "may", "shall", "will", or "would". Although Alkemy believes the expectations expressed in such forward‐looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those projected. Mining exploration and development is an inherently risky business. In addition, factors that could cause actual events to differ materially from the forward-looking information stated herein include any factors which affect decisions to pursue mineral exploration on the relevant property and the ultimate exercise of option rights, which may include changes in market conditions, changes in metal prices, general economic and political conditions, environmental risks, and community and non-governmental actions. Such factors will also affect whether Alkemy will ultimately receive the benefits anticipated pursuant to relevant agreements. This list is not exhaustive of the factors that may affect any of the forward‐looking statements. These and other factors should be considered carefully and readers should not place undue reliance on forward-looking information.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDSFMESIEESEDD
UK 100